{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T04:35:00Z","timestamp":1783744500161,"version":"3.55.0"},"reference-count":112,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2021,12,4]],"date-time":"2021-12-04T00:00:00Z","timestamp":1638576000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Infectious Disease Reports"],"abstract":"<jats:p>COVID-19 is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and has infected over 200 million people, causing over 4 million deaths. COVID-19 infection has been shown to lead to hypoxia, immunosuppression, host iron depletion, hyperglycemia secondary to diabetes mellitus, as well as prolonged hospitalizations. These clinical manifestations provide favorable conditions for opportunistic fungal pathogens to infect hosts with COVID-19. Interventions such as treatment with corticosteroids and mechanical ventilation may further predispose COVID-19 patients to acquiring fungal coinfections. Our literature review found that fungal coinfections in COVID-19 infected patients were most commonly caused by Aspergillus, Candida species, Cryptococcus neoformans, and fungi of the Mucorales order. The distribution of these infections, particularly Mucormycosis, was found to be markedly skewed towards low- and middle-income countries. The purpose of this review is to identify possible explanations for the increase in fungal coinfections seen in COVID-19 infected patients so that physicians and healthcare providers can be conscious of factors that may predispose these patients to fungal coinfections in order to provide more favorable patient outcomes. After identifying risk factors for coinfections, measures should be taken to minimize the dosage and duration of drugs such as corticosteroids, immunosuppressants, and antibiotics.<\/jats:p>","DOI":"10.3390\/idr13040093","type":"journal-article","created":{"date-parts":[[2021,12,7]],"date-time":"2021-12-07T03:21:05Z","timestamp":1638847265000},"page":"1018-1035","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":38,"title":["Root Causes of Fungal Coinfections in COVID-19 Infected Patients"],"prefix":"10.3390","volume":"13","author":[{"given":"Arman","family":"Amin","sequence":"first","affiliation":[{"name":"College of Osteopathic Medicine of the Pacific, Western University of Health Sciences, Pomona, CA 91766-1854, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Artin","family":"Vartanian","sequence":"additional","affiliation":[{"name":"School of Medicine, St. George\u2019s University, St. George\u2019s 999166, Grenada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1432-8467","authenticated-orcid":false,"given":"Nicole","family":"Poladian","sequence":"additional","affiliation":[{"name":"College of Osteopathic Medicine of the Pacific, Western University of Health Sciences, Pomona, CA 91766-1854, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Voloshko","sequence":"additional","affiliation":[{"name":"College of Osteopathic Medicine of the Pacific, Western University of Health Sciences, Pomona, CA 91766-1854, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9371-8641","authenticated-orcid":false,"given":"Aram","family":"Yegiazaryan","sequence":"additional","affiliation":[{"name":"College of Osteopathic Medicine of the Pacific, Western University of Health Sciences, Pomona, CA 91766-1854, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdul Latif","family":"Al-Kassir","sequence":"additional","affiliation":[{"name":"College of Osteopathic Medicine of the Pacific, Western University of Health Sciences, Pomona, CA 91766-1854, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2586-1160","authenticated-orcid":false,"given":"Vishwanath","family":"Venketaraman","sequence":"additional","affiliation":[{"name":"College of Osteopathic Medicine of the Pacific, Western University of Health Sciences, Pomona, CA 91766-1854, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,12,4]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Khan, M., Adil, S.F., Alkhathlan, H.Z., Tahir, M.N., Saif, S., Khan, M., and Khan, S.T. (2020). COVID-19: A global challenge with old history, epidemiology and progress so far. Molecules, 26.","DOI":"10.3390\/molecules26010039"},{"key":"ref_2","first-page":"753","article-title":"Origin, transmission, diagnosis, and management of coronavirus disease 2019 (COVID-19)","volume":"96","author":"Umakanthan","year":"2020","journal-title":"Postgrad Med. J."},{"key":"ref_3","unstructured":"Centers for Disease Control and Prevention (CDC) (2021, August 03). COVID Data Tracker, Available online: https:\/\/covid.cdc.gov\/covid-data-tracker\/#cases_totalcases."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Fakhroo, A.D., Al Thani, A.A., and Yassine, H.M. (2020). Markers associated with COVID-19 susceptibility, resistance, and severity. Viruses, 13.","DOI":"10.3390\/v13010045"},{"key":"ref_5","unstructured":"Centers for Disease Control and Prevention (CDC) (2021, August 18). People with Certain Medical Conditions, Available online: https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/need-extra-precautions\/people-with-medical-conditions.html."},{"key":"ref_6","unstructured":"World Health Organization (WHO) (2021, August 18). Coronavirus Disease (COVID-19): How is it Transmitted?. Available online: https:\/\/www.who.int\/emergencies\/diseases\/novel-coronavirus-2019\/question-and-answers-hub\/q-a-detail\/coronavirus-disease-covid-19-how-is-it-transmitted."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.cca.2020.05.044","article-title":"COVID-19: Transmission, prevention, and potential therapeutic opportunities","volume":"508","author":"Lotfi","year":"2020","journal-title":"Clin. Chim. Acta"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1136\/postgradmedj-2020-138577","article-title":"COVID-19: Current understanding of its pathophysiology, clinical presentation and treatment","volume":"97","author":"Parasher","year":"2021","journal-title":"Postgrad. Med. J."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s41232-020-00146-3","article-title":"How COVID-19 induces cytokine storm with high mortality","volume":"40","author":"Hojyo","year":"2020","journal-title":"Inflamm. Regen."},{"key":"ref_10","first-page":"E304","article-title":"Determine the most common clinical symptoms in COVID-19 patients: A systematic review and meta-analysis","volume":"61","author":"Alimohamadi","year":"2020","journal-title":"J. Prev. Med. Hyg."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s12575-020-00128-2","article-title":"A comprehensive review of COVID-19 characteristics","volume":"22","author":"Esakandari","year":"2020","journal-title":"Biol. Proced. Online"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"827","DOI":"10.3389\/fimmu.2020.00827","article-title":"Reduction and functional exhaustion of T cells in patients with coronavirus disease 2019 (COVID-19)","volume":"11","author":"Diao","year":"2020","journal-title":"Front. Immunol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"100971","DOI":"10.1016\/j.mycmed.2020.100971","article-title":"Invasive fungal diseases during COVID-19: We should be prepared","volume":"30","author":"Gangneux","year":"2020","journal-title":"J. Mycol. Med."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1007\/s11046-020-00462-9","article-title":"Fungal co-infections associated with global COVID-19 pandemic: A clinical and diagnostic perspective from China","volume":"185","author":"Song","year":"2020","journal-title":"Mycopathologia"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"925135","DOI":"10.1155\/2012\/925135","article-title":"CD4\u207aT cells: Differentiation and functions","volume":"2012","author":"Luckheeram","year":"2012","journal-title":"Clin. Dev. Immunol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1097\/MCP.0000000000000666","article-title":"Viral respiratory infections: A cause of community-acquired pneumonia or a predisposing factor?","volume":"26","author":"Arnold","year":"2020","journal-title":"Curr. Opin. Pulm. Med."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s41479-021-00083-w","article-title":"The role of co-infections and secondary infections in patients with COVID-19","volume":"13","author":"Feldman","year":"2021","journal-title":"Pneumonia"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/0002-9343(82)90414-4","article-title":"Superinfection: Another look","volume":"73","author":"Sen","year":"1982","journal-title":"Am. J. Med."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Musuuza, J.S., Watson, L., Parmasad, V., Putman-Buehler, N., Christensen, L., and Safdar, N. (2021). Prevalence and outcomes of co-infection and superinfection with SARS-CoV-2 and other pathogens: A systematic review and meta-analysis. PLoS ONE, 16.","DOI":"10.1371\/journal.pone.0251170"},{"key":"ref_20","unstructured":"Centers for Disease Control and Prevention (CDC) (2021, August 18). Fungal Diseases and COVID-19, Available online: https:\/\/www.cdc.gov\/fungal\/covid-fungal.html."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"7777","DOI":"10.1007\/s00253-020-10814-6","article-title":"The microbial coinfection in COVID-19","volume":"104","author":"Chen","year":"2020","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"e93156","DOI":"10.1172\/jci.insight.93156","article-title":"Immunity against fungi","volume":"2","author":"Lionakis","year":"2017","journal-title":"JCI Insight"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"e126","DOI":"10.15190\/d.2021.5","article-title":"High mortality co-infections of COVID-19 patients: Mucormycosis and other fungal infections","volume":"9","author":"Bhatt","year":"2021","journal-title":"Discoveries"},{"key":"ref_24","unstructured":"Centers for Disease Control and Prevention (CDC) (2021, October 10). Aspergillosis, Available online: https:\/\/www.cdc.gov\/fungal\/diseases\/aspergillosis\/index.html."},{"key":"ref_25","unstructured":"Centers for Disease Control and Prevention (CDC) (2021, October 10). Symptoms of COVID-19, Available online: https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/symptoms-testing\/symptoms.html."},{"key":"ref_26","unstructured":"Centers for Disease Control and Prevention (CDC) (2021, October 10). Candidiasis, Available online: https:\/\/www.cdc.gov\/fungal\/diseases\/candidiasis\/index.html."},{"key":"ref_27","unstructured":"Centers for Disease Control and Prevention (CDC) (2021, October 10). Symptoms of C. neoformans Infection, Available online: https:\/\/www.cdc.gov\/fungal\/diseases\/cryptococcosis-neoformans\/symptoms.html."},{"key":"ref_28","unstructured":"Centers for Disease Control and Prevention (CDC) (2021, October 10). Symptoms of Mucormycosis, Available online: https:\/\/www.cdc.gov\/fungal\/diseases\/mucormycosis\/symptoms.html."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"106031","DOI":"10.1016\/j.ijsu.2021.106031","article-title":"Mucormycosis coinfection in the context of global COVID-19 outbreak: A fatal addition to the pandemic spectrum","volume":"92","author":"Devnath","year":"2021","journal-title":"Int. J. Surg."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Skiada, A., Pavleas, I., and Drogari-Apiranthitou, M. (2020). Epidemiology and diagnosis of mucormycosis: An update. J. Fungi, 6.","DOI":"10.3390\/jof6040265"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1093\/trstmh\/try124","article-title":"The double burden of diabetes and global infection in low and middle-income countries","volume":"113","author":"Dunachie","year":"2019","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"ref_32","unstructured":"The World Bank (2021, October 10). High Income. Available online: https:\/\/data.worldbank.org\/income-level\/high-income."},{"key":"ref_33","unstructured":"The World Bank (2021, October 10). Middle Income. Available online: https:\/\/data.worldbank.org\/income-level\/middle-income."},{"key":"ref_34","unstructured":"The World Bank (2021, October 10). Low Income. Available online: https:\/\/data.worldbank.org\/income-level\/low-income."},{"key":"ref_35","unstructured":"World Health Organization (WHO) (2021, October 10). List of 57 Countries Facing Human Resources for Health Crisis. Available online: https:\/\/www.who.int\/workforcealliance\/countries\/57crisiscountries.pdf?ua=1."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"102146","DOI":"10.1016\/j.dsx.2021.05.019","article-title":"Mucormycosis in COVID-19: A systematic review of cases reported worldwide and in India","volume":"15","author":"Singh","year":"2021","journal-title":"Diabetes Metab. Syndr."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S2213-2600(20)30079-5","article-title":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: A single-centered, retrospective, observational study","volume":"8","author":"Yang","year":"2020","journal-title":"Lancet Respir. Med."},{"key":"ref_38","first-page":"e14726","article-title":"SARS CoV-2 related microvascular damage and symptoms during and after COVID-19: Consequences of capillary transit-time changes, tissue hypoxia and inflammation","volume":"9","year":"2021","journal-title":"Physiol. Rep."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"2243.e5","DOI":"10.1016\/j.ajem.2020.05.044","article-title":"Silent hypoxia: A harbinger of clinical deterioration in patients with COVID-19","volume":"38","author":"Wilkerson","year":"2020","journal-title":"Am. J. Emerg. Med."},{"key":"ref_40","unstructured":"Bhutta, B.S., Alghoula, F., and Berim, I. (2021, August 03). Hypoxia, StatPearls, Available online: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK482316\/."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.3389\/fmicb.2020.01920","article-title":"Hypoxia: A double-edged sword during fungal pathogenesis?","volume":"11","author":"Chung","year":"2020","journal-title":"Front. Microbiol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"109857","DOI":"10.1016\/j.mehy.2020.109857","article-title":"Hypoxia inducible factor-1 protects against COVID-19: A hypothesis","volume":"143","author":"Afsar","year":"2020","journal-title":"Med. Hypotheses"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1128\/EC.00031-12","article-title":"Hypoxia and fungal pathogenesis: To air or not to air?","volume":"11","author":"Grahl","year":"2012","journal-title":"Eukaryot. Cell"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1038\/s41401-020-00554-8","article-title":"Hypoxia, HIF-1\u03b1, and COVID-19: From pathogenic factors to potential therapeutic targets","volume":"41","author":"Serebrovska","year":"2020","journal-title":"Acta Pharmacol. Sinica"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"18579","DOI":"10.1074\/jbc.RA120.015303","article-title":"High affinity binding of SARS-CoV-2 spike protein enhances ACE2 carboxypeptidase activity","volume":"295","author":"Lu","year":"2020","journal-title":"J. Biol. Chem."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1186\/s13054-020-03120-0","article-title":"Role of angiotensin-converting enzyme 2 (ACE2) in COVID-19","volume":"24","author":"Ni","year":"2020","journal-title":"Crit. Care"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1515\/biol-2021-0034","article-title":"Diabetes and COVID-19","volume":"16","author":"Gazzaz","year":"2021","journal-title":"Open Life Sci."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.15537\/smj.2020.10.25419","article-title":"Risk factors for hospital admission among COVID-19 patients with diabetes. A study from Saudi Arabia","volume":"41","author":"Robert","year":"2020","journal-title":"Saudi Med. J."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1177\/1932296820924469","article-title":"Glycemic characteristics and clinical outcomes of COVID-19 patients hospitalized in the United States","volume":"14","author":"Bode","year":"2020","journal-title":"J. Diabetes Sci. Technol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.imbio.2010.06.002","article-title":"High glucose disrupts oligosaccharide recognition function via competitive inhibition: A potential mechanism for immune dysregulation in diabetes mellitus","volume":"216","author":"Ilyas","year":"2011","journal-title":"Immunobiology"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1006\/mgme.2001.3185","article-title":"Impairment of type III group B Streptococcus-stimulated superoxide production and opsonophagocytosis by neutrophils in diabetes","volume":"73","author":"Mazade","year":"2001","journal-title":"Mol. Genet. Metab."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1111\/j.1582-4934.2009.00803.x","article-title":"Methylglyoxal modulates immune responses: Relevance to diabetes","volume":"14","author":"Price","year":"2010","journal-title":"J. Cell Mol. Med."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.cmi.2020.07.041","article-title":"Incidence of co-infections and superinfections in hospitalized patients with COVID-19: A retrospective cohort study","volume":"27","author":"Sanjuan","year":"2021","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1093\/cid\/cir865","article-title":"Pathogenesis of mucormycosis","volume":"54","author":"Ibrahim","year":"2012","journal-title":"Clin. Infect. Dis."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"271","DOI":"10.2337\/diab.39.3.271","article-title":"Handicaps to host defense. Effects of hyperglycemia on C3 and Candida albicans","volume":"39","author":"Hostetter","year":"1990","journal-title":"Diabetes"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"103492","DOI":"10.1016\/j.resp.2020.103492","article-title":"Pros and cons of corticosteroid therapy for COVID-19 patients","volume":"280","author":"Felix","year":"2020","journal-title":"Respir. Physiol. Neurobiol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"e01648-20","DOI":"10.1128\/JVI.01648-20","article-title":"The inhaled steroid ciclesonide blocks SARS-CoV-2 RNA replication by targeting the viral replication-transcription complex in cultured cells","volume":"95","author":"Matsuyama","year":"2020","journal-title":"J. Virol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1001\/jama.2020.17021","article-title":"Effect of dexamethasone on days alive and ventilator-free in patients with moderate or severe acute respiratory distress syndrome and COVID-19: The CoDEX randomized clinical trial","volume":"324","author":"Tomazini","year":"2020","journal-title":"JAMA"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.2217\/fmb-2020-0156","article-title":"Systemic mycoses: A potential alert for complications in COVID-19 patients","volume":"15","author":"Frases","year":"2020","journal-title":"Future Microbiol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"6417","DOI":"10.1172\/JCI140617","article-title":"Corticosteroid treatment in severe COVID-19 patients with acute respiratory distress syndrome","volume":"130","author":"Liu","year":"2020","journal-title":"J. Clin. Investig."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1056\/NEJMoa2021436","article-title":"Dexamethasone in hospitalized patients with Covid-19","volume":"384","author":"Horby","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"102167","DOI":"10.1016\/j.dsx.2021.06.004","article-title":"Steroid use during COVID-19 infection and hyperglycemia\u2014What a physician should know","volume":"15","author":"Sosale","year":"2021","journal-title":"Diabetes Metab. Syndr."},{"key":"ref_63","first-page":"e72","article-title":"Ferritin levels and COVID-19","volume":"44","year":"2020","journal-title":"Rev. Panam. Salud P\u00fablica"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.12669\/pjms.35.4.1003","article-title":"Influence of ferritin levels and inflammatory markers on HbA1c in the Type 2 diabetes mellitus patients","volume":"35","author":"Son","year":"2019","journal-title":"Pak. J. Med. Sci."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"111228","DOI":"10.1016\/j.biopha.2021.111228","article-title":"The role of iron in the pathogenesis of COVID-19 and possible treatment with lactoferrin and other iron chelators","volume":"136","author":"Habib","year":"2021","journal-title":"Biomed. Pharmacother."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1002\/lt.20827","article-title":"Association of hepatic iron overload with invasive fungal infection in liver transplant recipients","volume":"12","author":"Alexander","year":"2006","journal-title":"Liver Transpl."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/S0163-4453(84)93955-0","article-title":"Functional defects in phagocytic cells from patients with iron overload","volume":"8","author":"Marx","year":"1984","journal-title":"J. Infect."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1007\/s12663-021-01532-1","article-title":"SARS-CoV-2, uncontrolled diabetes and corticosteroids\u2014An unholy trinity in invasive fungal infections of the maxillofacial region? A retrospective, multi-centric analysis","volume":"20","author":"Moorthy","year":"2021","journal-title":"J. Maxillofac. Oral Surg."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.1172\/JCI32338","article-title":"The iron chelator deferasirox protects mice from mucormycosis through iron starvation","volume":"117","author":"Ibrahim","year":"2007","journal-title":"J. Clin. Investig."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1093\/jac\/dkl350","article-title":"Deferiprone iron chelation as a novel therapy for experimental mucormycosis","volume":"58","author":"Ibrahim","year":"2006","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1172\/JCI116419","article-title":"Mucormycosis during deferoxamine therapy is a siderophore-mediated infection. In vitro and in vivo animal studies","volume":"91","author":"Boelaert","year":"1993","journal-title":"J. Clin. Investig."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"413","DOI":"10.2174\/187152611796504827","article-title":"Microaspiration in intubated critically ill patients: Diagnosis and prevention","volume":"11","author":"Nseir","year":"2011","journal-title":"Infect. Disord. Drug Targets"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1016\/j.jiph.2021.08.003","article-title":"Bacterial and fungal ventilator associated pneumonia in critically ill COVID-19 patients during the second wave","volume":"14","author":"Meawed","year":"2021","journal-title":"J. Infect. Public Health"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1164\/rccm.202009-3400OC","article-title":"Occurrence of invasive pulmonary fungal infections in patients with severe COVID-19 admitted to the ICU","volume":"203","author":"Fekkar","year":"2021","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1007\/s12281-010-0034-6","article-title":"T-cell subsets and antifungal host defenses","volume":"4","author":"Netea","year":"2010","journal-title":"Curr. Fungal Infect. Rep."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.3109\/13693786.2010.505204","article-title":"Clinical risk factors for invasive aspergillosis","volume":"49","author":"Baddley","year":"2011","journal-title":"Med Mycol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/S2213-2600(21)00138-7","article-title":"COVID-19-associated Aspergillus tracheobronchitis: The interplay between viral tropism, host defence, and fungal invasion","volume":"9","author":"Vos","year":"2021","journal-title":"Lancet Respir. Med."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"104554","DOI":"10.1016\/j.micpath.2020.104554","article-title":"Immunopathological similarities between COVID-19 and influenza: Investigating the consequences of Co-infection","volume":"152","author":"Khorramdelazad","year":"2021","journal-title":"Microb. Pathog."},{"key":"ref_79","doi-asserted-by":"crossref","unstructured":"Bartoletti, M., Pascale, R., Cricca, M., Rinaldi, M., Maccaro, A., Bussini, L., Fornaro, G., Tonetti, T., Pizzilli, G., and Francalanci, E. (2020). Epidemiology of invasive pulmonary aspergillosis among intubated patients with COVID-19: A prospective study. Clin. Infect. Dis., 1065.","DOI":"10.1093\/cid\/ciaa1065"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"e149","DOI":"10.1016\/S1473-3099(20)30847-1","article-title":"Defining and managing COVID-19-associated pulmonary aspergillosis: The 2020 ECMM\/ISHAM consensus criteria for research and clinical guidance","volume":"21","author":"Koehler","year":"2021","journal-title":"Lancet Infect. Dis."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1111\/myc.13096","article-title":"COVID-19 associated pulmonary aspergillosis","volume":"63","author":"Koehler","year":"2020","journal-title":"Mycoses"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"e1634","DOI":"10.1093\/cid\/ciaa1298","article-title":"A national strategy to diagnose COVID-19 associated invasive fungal disease in the ICU","volume":"73","author":"White","year":"2020","journal-title":"Clin. Infect. Dis. Off. Publ. Infect. Dis. Soc. Am."},{"key":"ref_83","first-page":"790.e1","article-title":"Risk factors associated with COVID-19-associated pulmonary aspergillosis in ICU patients: A French multicentric retrospective cohort","volume":"27","author":"Dudoignon","year":"2020","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1086\/322793","article-title":"Impaired antifungal effector activity but not inflammatory cell recruitment in interleukin-6-deficient mice with invasive pulmonary aspergillosis","volume":"184","author":"Cenci","year":"2001","journal-title":"J. Infect. Dis."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.jmii.2020.09.004","article-title":"COVID-19 associated with pulmonary aspergillosis: A literature review","volume":"54","author":"Lai","year":"2021","journal-title":"J. Microbiol. Immunol. Infect. Mian Yu Gan Ran Za Zhi"},{"key":"ref_86","first-page":"4174","article-title":"Immunomodulatory agents as potential therapeutic or preventive strategies for Covid-19","volume":"25","author":"Gaziano","year":"2021","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mib.2020.05.004","article-title":"Minority report: The intestinal mycobiota in systemic infections","volume":"56","author":"Rolling","year":"2020","journal-title":"Curr. Opin. Microbiol."},{"key":"ref_88","doi-asserted-by":"crossref","unstructured":"Arastehfar, A., Carvalho, A., Nguyen, M.H., Hedayati, M.T., Netea, M.G., Perlin, D.S., and Hoenigl, M. (2020). COVID-19-associated candidiasis (CAC): An underestimated complication in the absence of immunological predispositions. J. Fungi, 6.","DOI":"10.3390\/jof6040211"},{"key":"ref_89","first-page":"813","article-title":"Outbreak of Candida auris infection in a COVID-19 hospital in Mexico","volume":"27","year":"2021","journal-title":"Clin. Microbiol. Infect. Off. Publ. Eur. Soc. Clin. Microbiol. Infect. Dis."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1111\/myc.13137","article-title":"Oropharyngeal candidiasis in hospitalised COVID-19 patients from Iran: Species identification and antifungal susceptibility pattern","volume":"63","author":"Salehi","year":"2020","journal-title":"Mycoses"},{"key":"ref_91","doi-asserted-by":"crossref","unstructured":"Williams, D., and Lewis, M. (2011). Pathogenesis and treatment of oral candidosis. J. Oral Microbiol., 3.","DOI":"10.3402\/jom.v3i0.5771"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"395","DOI":"10.33073\/pjm-2021-039","article-title":"Fungal infections in COVID-19 intensive care patients","volume":"70","author":"Durmaz","year":"2021","journal-title":"Pol. J. Microbiol."},{"key":"ref_93","doi-asserted-by":"crossref","unstructured":"World Health Organization (2020). Clinical Management of COVID-19: Interim Guidance, 27 May 2020, World Health Organization. Available online: https:\/\/apps.who.int\/iris\/handle\/10665\/332196.","DOI":"10.15557\/PiMR.2020.0004"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"102564","DOI":"10.1016\/j.autrev.2020.102564","article-title":"Tocilizumab for cytokine storm syndrome in COVID-19 pneumonia: An increased risk for candidemia?","volume":"19","author":"Antinori","year":"2020","journal-title":"Autoimmun. Rev."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1046\/j.1365-280X.1999.00247.x","article-title":"Increased susceptibility to systemic candidiasis in interleukin-6 deficient mice","volume":"37","author":"Netea","year":"1999","journal-title":"Med Mycol."},{"key":"ref_96","unstructured":"Seagle, E.E., Jackson, B.R., Lockhart, S.R., Georgacopoulos, O., Nunnally, N.S., Roland, J., Barter, D.M., Johnston, H.L., Czaja, C.A., and Kayalioglu, H. (2021). The landscape of candidemia during the COVID-19 pandemic. Clin. Infect. Dis., ciab562."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"S618","DOI":"10.1093\/cid\/civ815","article-title":"The role of echinocandins in Candida biofilm\u2013related vascular catheter infections: In vitro and in vivo model systems","volume":"61","author":"Ghannoum","year":"2015","journal-title":"Clin. Infect. Dis."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1378\/chest.129.1.110","article-title":"Outcomerea Study Group. Candida colonization of the respiratory tract and subsequent pseudomonas ventilator-associated pneumonia","volume":"129","author":"Azoulay","year":"2006","journal-title":"Chest"},{"key":"ref_99","first-page":"597","article-title":"A prospective study of fungal colonization and invasive fungal disease in long-term mechanically ventilated patients in a respiratory intensive care unit","volume":"22","author":"Chakraborti","year":"2018","journal-title":"Indian J. Crit. Care Med. Peer Rev. Off. Publ. Indian Soc. Crit. Care Med."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.idc.2015.10.006","article-title":"Cryptococcosis","volume":"30","author":"Maziarz","year":"2016","journal-title":"Infect. Dis. Clin. N. Am."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1093\/qjmed\/95.8.511","article-title":"Cryptococcaemia: Clinical features and prognostic factors","volume":"95","author":"Jean","year":"2002","journal-title":"QJM Mon. J. Assoc. Physicians"},{"key":"ref_102","doi-asserted-by":"crossref","unstructured":"Passarelli, V.C., Perosa, A.H., de Souza Luna, L.K., Conte, D.D., Nascimento, O.A., Ota-Arakaki, J., and Bellei, N. (2020). Detected SARS-CoV-2 in ascitic fluid followed by cryptococcemia: A case report. SN Compr. Clin. Med., 2414\u20132418.","DOI":"10.1007\/s42399-020-00574-9"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1002\/ccr3.3668","article-title":"Cryptococcemia in a patient with COVID-19: A case report","volume":"9","author":"Khatib","year":"2020","journal-title":"Clin. Case Rep."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"5302","DOI":"10.1128\/IAI.00661-06","article-title":"(2006). Role of capsule and interleukin-6 in long-term immune control of Cryptococcus neoformans infection by specifically activated human peripheral blood mononuclear cells","volume":"74","author":"Siddiqui","year":"2006","journal-title":"Infect. Immun."},{"key":"ref_105","first-page":"5597473","article-title":"Cryptococcus neoformans meningoencephalitis in an immunocompetent patient after COVID-19 infection","volume":"2021","author":"Ghanem","year":"2021","journal-title":"Case Rep. Infect. Dis."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.cmi.2018.07.011","article-title":"The epidemiology and clinical manifestations of mucormycosis: A systematic review and meta-analysis of case reports","volume":"25","author":"Jeong","year":"2019","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"e405","DOI":"10.1016\/S1473-3099(19)30312-3","article-title":"Global guideline for the diagnosis and management of mucormycosis: An initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium; Mucormycosis ECMM MSG Global Guideline Writing Group","volume":"19","author":"Cornely","year":"2019","journal-title":"Lancet Infect. Dis."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/S0272-6386(12)80606-8","article-title":"Deferoxamine therapy and mucormycosis in dialysis patients: Report of an international registry","volume":"18","author":"Boelaert","year":"1991","journal-title":"Am. J. Kidney Dis."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1080\/23744235.2016.1239027","article-title":"Saksenaea erythrospora, an emerging mucoralean fungus causing severe necrotizing skin and soft tissue infections\u2014A study from a tertiary care hospital in north India","volume":"49","author":"Chander","year":"2017","journal-title":"Infect. Dis."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1111\/myc.13338","article-title":"COVID-19-associated mucormycosis: An updated systematic review of literature","volume":"64","author":"Pal","year":"2021","journal-title":"Mycoses"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.2337\/diacare.31.12.1109","article-title":"A mechanism of susceptibility to mucormycosis in diabetic ketoacidosis: Transferrin and iron availability","volume":"31","author":"Artis","year":"1982","journal-title":"Diabetes"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1080\/10428190310001653691","article-title":"Improved outcome of zygomycosis in patients with hematological diseases?","volume":"45","author":"Gleissner","year":"2004","journal-title":"Leuk. Lymphoma"}],"container-title":["Infectious Disease Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2036-7449\/13\/4\/93\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T07:39:53Z","timestamp":1760168393000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2036-7449\/13\/4\/93"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,4]]},"references-count":112,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["idr13040093"],"URL":"https:\/\/doi.org\/10.3390\/idr13040093","relation":{},"ISSN":["2036-7449"],"issn-type":[{"value":"2036-7449","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12,4]]}}}